Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 6, p. 2919, doi. 10.3390/ijms22062919

By:

• Grobs, Yann;
• Awada, Charifa;
• Lemay, Sarah-Eve;
• Romanet, Charlotte;
• Bourgeois, Alice;
• Toro, Victoria;
• Nadeau, Valérie;
• Shimauchi, Kana;
• Orcholski, Mark;
• Breuils-Bonnet, Sandra;
• Tremblay, Eve;
• Provencher, Steeve;
• Paulin, Roxane;
• Boucherat, Olivier;
• Bonnet, Sébastien;
• Yamawaki, Hideyuki

Publication type:

Article